Curocell Inc. (372320)
Market Closed
10 Aug, 06:30
KRX SM KRX SM Primary ₩
27,900. 00
+950
+3.525%
₩
802.42B Market Cap
- P/E Ratio
- Div Yield
330,922 Volume
- Eps
₩ 26,950
Previous Close Want to track 372320 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
372320 closed today higher at ₩27,900, an increase of 3.525% from yesterday's close, completing a monthly decrease of -10.2894% or -₩3,200. Over the past 12 months, 372320 stock lost -38.3425%.
372320 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.
Curocell Inc. (372320) FAQ
What is the stock price today?
The current price is ₩27,900.00.
On which exchange is it traded?
Curocell Inc. is listed on KRX SM.
What is its stock symbol?
The ticker symbol is 372320.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 802.42B.
Has Curocell Inc. ever had a stock split?
No, there has never been a stock split.
Curocell Inc. Profile
| Biotechnology Industry | Healthcare Sector | Mr. Kim Gunsoo CEO | KRX SM Exchange | - ISIN |
| South Korea Country | 136 Employees | - Last Dividend | - Last Split | - IPO Date |
Curocell Inc. is a biotechnology company focused on the development and commercialization of innovative cell-based therapies. Specializing in CAR-T cell therapy, Curocell utilizes advanced biotechnological practices to target and treat various forms of cancer. The company's primary objective is to harness T-cell engineering to create cutting-edge solutions for patients with limited treatment options. Curocell operates within the healthcare sector, impacting both the biotechnology and pharmaceutical industries through its research and development efforts. With a strong emphasis on precision medicine, Curocell aims to address unmet medical needs by delivering personalized therapeutic solutions. By pioneering advancements in cell therapy technology, Curocell plays a pivotal role in the evolving landscape of cancer treatment, contributing to more effective and targeted therapeutic approaches.
Contact Information
Address: 11 Gukje Science 16-ro
Phone: 82 4 2863 3698
Website: https://www.curocellbtx.com
